- Home
- INZY vs AEYE Comparison
INZY vs AEYE Comparison
Compare INZY & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- AEYE
- Stock Information
- Founded
- INZY 2015
- AEYE 2005
- Country
- INZY United States
- AEYE United States
- Employees
- INZY N/A
- AEYE N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- AEYE Computer Software: Prepackaged Software
- Sector
- INZY Health Care
- AEYE Technology
- Exchange
- INZY Nasdaq
- AEYE Nasdaq
- Market Cap
- INZY 321.4M
- AEYE 278.0M
- IPO Year
- INZY 2020
- AEYE N/A
- Fundamental
- Price
- INZY $3.13
- AEYE $25.51
- Analyst Decision
- INZY Strong Buy
- AEYE Strong Buy
- Analyst Count
- INZY 7
- AEYE 4
- Target Price
- INZY $16.14
- AEYE $30.13
- AVG Volume (30 Days)
- INZY 313.3K
- AEYE 221.5K
- Earning Date
- INZY 11-05-2024
- AEYE 11-07-2024
- Dividend Yield
- INZY N/A
- AEYE N/A
- EPS Growth
- INZY N/A
- AEYE N/A
- EPS
- INZY N/A
- AEYE N/A
- Revenue
- INZY N/A
- AEYE $33,348,000.00
- Revenue This Year
- INZY N/A
- AEYE $13.79
- Revenue Next Year
- INZY N/A
- AEYE $18.88
- P/E Ratio
- INZY N/A
- AEYE N/A
- Revenue Growth
- INZY N/A
- AEYE 6.94
- 52 Week Low
- INZY $3.08
- AEYE $3.97
- 52 Week High
- INZY $7.80
- AEYE $34.85
- Technical
- Relative Strength Index (RSI)
- INZY 19.15
- AEYE 50.81
- Support Level
- INZY $4.02
- AEYE $23.99
- Resistance Level
- INZY $4.74
- AEYE $34.85
- Average True Range (ATR)
- INZY 0.27
- AEYE 2.50
- MACD
- INZY -0.11
- AEYE 0.15
- Stochastic Oscillator
- INZY 2.65
- AEYE 32.76
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.